Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule

Psychopharmacology

Volumn 232, Issue 4, 2015, Pages 699-711

  Bezzina, G ^a   Body, S ^a   Cheung, T H C ^a   Hampson, C L ^a   Bradshaw, C M ^a   Glennon, J C ^b   Szabadi, E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 HT2C receptors; Incentive value; Mathematical model; Mathematical principles of reinforcement; mCPP; Motor capacity; Progressive ratio schedule; Rats; Ro 600175

Indexed keywords

2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 6-CHLORO-5-METHYL-1-((2-(2-METHYLPYRID-3-YLOXY)PYRID-5-YL)CARBAMOYL)INDOLINE; AMINOPYRIDINE DERIVATIVE; ETHYLAMINE; FLUOROBENZENE; INDOLE DERIVATIVE; PIPERIDINE DERIVATIVE; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2C RECEPTOR; VOLINANSERIN;

ANIMAL; FOOD; MALE; MOTIVATION; PHYSIOLOGY; RAT; REACTION TIME; REINFORCEMENT; WISTAR RAT;

AMINOPYRIDINES; ANIMALS; ETHYLAMINES; FLUOROBENZENES; FOOD; INDOLES; MALE; MOTIVATION; PIPERIDINES; RATS; RATS, WISTAR; REACTION TIME; RECEPTOR, SEROTONIN, 5-HT2C; REINFORCEMENT (PSYCHOLOGY); SEROTONIN 5-HT2 RECEPTOR AGONISTS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 84922454757     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3700-5     Document Type: Article

References (98)

1. Aberman JE, Ward SJ, Salamone JD (1998) Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacol Biochem Behav 61:341-348
2. 1B receptor antagonist isamoltane in citalopram-pretreated male rats. Pharm Pharmacol Comm 6:317-320
3. Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296-320
4. 2C receptors. Synapse 55:242-251
5. Arnold JM, Roberts DCS (1997) A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57:441-447
6. Baunez C, Amalric M, Robbins TW (2002) Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus. J Neurosci 22:562-568
7. Bezzina G, Body S, Cheung THC, Hampson CL, Deakin JFW, Anderson IM, Szabadi E, Bradshaw CM (2008) Effect of quinolinic acid-induced lesions of the nucleus accumbens core on performance on a progressive ratio schedule of reinforcement: implications for inter-temporal choice. Psychopharmacology 197:339-350
8. 2C receptor agonists as potential drugs for the treatment of obesity. Curr Topics Med Chem 3:885-897
9. Bizo LA, Killeen PR (1997) Models of ratio schedule performance. J Exp Psychol Anim Behav Process 23:351-367
10. Bizo LA, Kettle LC, Killeen PR (2001) Rats don't always respond faster for more food. Anim Learn Behav 29:66-78
11. 2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum. Behav Proc 71:258-267
12. 2A receptors. Psychopharmacology 189:331-343
13. Body S, Cheung THC, Bezzina G, Hampson CL, Fone KCF, Bradshaw CM, Glennon JC, Szabadi E (2014) New findings on the sensitivity of free-operant timing behaviour to 5-hydroxytryptamine receptor stimulation. Timing Time Percep
14. Bradshaw CM, Killeen PR (2012) A theory of behaviour on progressive ratio schedules, with applications in behavioural pharmacology. Psychopharmacology 222:549-564
15. Bubar MJ, Cunningham KA (2006) Serotonin (5-HT) and 5-HT receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem 6:1971-1985
16. 2C Receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathway. PLoS ONE 6(6):e20508
17. 2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats. Psychopharmacology 196:15-27
18. Covarrubias P, Aparicio CF (2008) Effects of reinforcer quality and step size on rats' performance under progressive ratio schedules. Behav Process 78:246-252
19. Cunningham KA, Fox RG, Anastasio NC, Bubar MJ, Stutz SJ, Moeller FG, Gilbertson SR, Rosenzweig-Lipson S (2011) Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine vs. sucrose-associated cues. Neuropharmacology 61:513-523
20. Czachowski CL, Samson HH (1999) Breakpoint determination and ethanol self-administration using an across-session progressive ratio procedure in the rat. Alcohol Clin Exp Res 23:1580-15866
21. Dalton GL, Lee MD, Kennett GA, Dourish CT, Clifton PT (2004) mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes. Neuropharmacology 46:663-671
22. De Deurwaerdere P, Chesselet MF (2000) Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats. J Neurosci 20:5170-5178
23. 2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24:3235-3241
24. 2C receptors upon basal ganglia function: from physiology to pathophysiology. Exp Brain Res 230:477-511
25. Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T, Daszuta A, Soumier A, Papp M, Rivet J-M, Flik G, Cremers TI, Muller O, Lavielle G, Millan MJ (2008) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology 119:549-568
26. Di Giovanni G, Di Matteo V, La Grutta V, Esposito E (2001) m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 103:111-116
27. Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1999) SB242084, a selective serotonin-2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:1195-1205
28. Di Matteo V, Pierucci M, Esposito E (2004) Selective stimulation of serotonin-2C receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. J Neurochem 89:418-429
29. Di Matteo V, Di Giovanni G, Pierucci M, Esposito E (2008) Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies. Prog Brain Res 172:7-44
30. Filip M, Bader M (2009) Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol Rep 61:761-777
31. 2C) receptors in rat prefrontal cortex. J Pharm Exp Ther 306:734-743
32. Filip M, Bubar MJ, Cunningham KA (2004) Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310:1246-1254
33. Filip M, Alenina N, Bader M, Przegaliński E (2010) Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addict Biol 15:227-249
34. Filip M, Spampinato U, McCreary AC, Przegaliński E (2012) Pharmacological and genetic interventions in serotonin (5-HT)2C receptors to alter drug abuse and dependence processes. Brain Res 1476:132-153
35. 2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology 29:308-318
36. 2C receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology 187:515-525
37. Fletcher PJ, Le AD, Higgins GA (2008) Serotonin receptors as potential targets for modulation of nicotine use and dependence. Prog Brain Res 172:361-383
38. Fletcher PJ, Tampakeras M, Sinyard J, Slassi A, Isaac M, Higgins GA (2009) Characterizing the effects of 5-HT2C receptor ligands on motor activity and feeding behaviour in 5-HT2C receptor knockout mice. Neuropharmacology 57:259-267
39. 2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 97:170-178
40. 2A receptor antagonist M100907 on nicotine self-administration and reinstatement. Neuropharmacology 62:2288-2298
41. 2C receptors to multiple actions of central serotonin systems. Eur J Pharmacol 488:1-9
42. 2B receptors. Behav Pharmacol 12:613-620
43. 2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36:205-221
44. Gommans J, Hijzen TH, Pattij T, van der Gutgen J, Olivier B (1999) Discriminative stimulus properties of mCPP and alprazolam are not mediated by anxiety. Pharmacol Biochem Behav 64:385-387
45. 2C receptors. Behav Brain Res 142:175-179
46. Graves SM, Viskniskki AA, Cunningham KA, Napier TC (2013) Serotonin(2C) receptors in the ventral pallidum regulate motor function in rats. Neuroreport 24:605-608
47. Griffiths RR, Brady JV, Snell JD (1978) Progressive-ratio performance maintained by drug infusions: comparison of cocaine, diethylpropion, chlorphentermine, and fenfluramine. Psychopharmacology 56:5-13
48. 2C receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 295:1183-1191
49. 2C receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology 157:292-298
50. Halford JCG, Harrold JA, Lawton CL, Blundell JE (2005) Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. Curr Drug Targets 6:201-213
51. Hamik A, Peroutka SJ (1989) 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiat 25:569-575
52. 2C receptors. Eur J Pharmacol 480:151-162
53. 2 agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine. Br J Pharmacol 133:459-466
54. 2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control. Neuropsychopharmacology 37:1177-1191
55. 2C receptor agonists on behaviours motivated by food and nicotine and on side effect profiles. Psychopharmacology 226:475-490
56. Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134:943-944
57. Hodos W, Kalman G (1963) Effects of increment size and reinforcer volume on progressive ratio performance. J Exp Anal Behav 6:387-392
58. 1 recognition sites. J Recept Res 8:59-81
59. 2C receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience 144:1523-1535
60. 2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine. Psychopharmacology 213:337-354
61. 1C receptors. Br J Pharmacol 94:137-147
62. Kennett GA, Lightowler S, Trail B, Bright F, Bromidge S (2000) Effects of RO 60-0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety. Eur J Pharmacol 387:197-204
63. Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609-620
64. Khaliq S, Irfan B, Haider S, Halleem DJ (2008) m-CPP induced hypolocomotion does not interfere in the assessment of memory functions in rats. Pak J Pharm Sci 21:139-143
65. Killeen PR (1994) Mathematical principles of reinforcement. Behav Brain Sci 17:105-172
66. Killeen PR, Posadas-Sanchez D, Johansen EB, Thrailkill EA (2009) Progressive ratio schedules of reinforcement. J Exp Psychol: Anim Behav Proc 35:35-50
67. 2C agonist, decreases nicotine self-administration in female rats. J Pharmacol Exp Ther 338:890-896
68. Lucki I, Ward HR, Frazer A (1989) Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J Pharmacol Exp Ther 249:155-164
69. Marston OJ, Heisler LK (2009) Targeting the serotonin 2C receptor for the treatment of obesity and type 2 diabetes. Neuropsychopharmacology 34:252-253
70. 2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286:913-924
71. Millan MJ, Dekeyne A, Gobert A (1998) Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37:953-955
72. Miller KJ (2005) Serotonin 5-HT2c receptor agonists: potential for the treatment of obesity. Molec Interventions 5:282-291
73. Mosher T, Hayes D, Greenshaw A (2005) Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats. Eur J Pharmacol 515:107-116
74. Nefs G, Pouwer F, Denollet J, Kramer H, Wijnands-van Gent CJ, Pop VJ (2012) Suboptimal glycemic control in type 2 diabetes: a key role for anhedonia? J Psychiatr Res 46:549-554
75. 2C) receptor agonists as potential antiobesity agents. J Med Chem 49:4023-4034
76. Olarte-Sánchez CM, Valencia-Torres L, Body S, Cassaday HJ, Bradshaw CM, Szabadi E, Goudie AJ (2012a) A clozapine-like effect of cyproheptadine on progressive-ratio schedule performance. J Psychopharm 26:857-870
77. Olarte-Sánchez CM, Valencia-Torres L, Body S, Cassaday HJ, Bradshaw CM, Szabadi E (2012b) Effect of orexin-B-saporin induced lesions of the lateral hypothalamus on a progressive-ratio schedule. J Psychopharm 26:871-886
78. Olarte-Sánchez CM, Valencia-Torres L, Cassaday HJ, Bradshaw CM, Szabadi E (2013) Effects of SKF-83566 and haloperidol on performance on progressive ratio schedules maintained by sucrose and corn oil reinforcement: quantitative analysis using a new model derived from the Mathematical Principles of Reinforcement (MPR). Psychopharmacology 230:617-630
79. 2C receptor involvement in the control of persistence in the reinforced spatial alternation animal model of obsessive-compulsive disorde. Behav Brain Res 243:176-183
80. Ping-Teng C, Lee ES, Konz SA, Richardson NR, Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Meth 66:1-11
81. 2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26:311-324
82. Randall PA, Pardo M, Nunes EJ, López Cruz L, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD (2012) Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. PLoS ONE 7(10):e47934
83. Reilly MP (2003) Extending mathematical principles of reinforcement into the domain of behavioral pharmacology. Behav Proc 62:75-88
84. Rickard JF, Body S, Zhang Z, Bradshaw CM, Szabadi E (2009) Effect of reinforcer magnitude on performance maintained by progressive-ratio schedules. J Exp Anal Behav 91:75-87
85. Roberts DCS, Richardson NR (1992) Self-administration of psychostimulants using progressive ratio schedules of reinforcement. In: Boulton A, Baker G, Wu PH (eds) Neuromethods., vol 24: animal models of drug addiction. New York, Humana, pp 233-269
86. Sanabria F, Acosta JI, Killeen PR, Neisewander JL, Bizo LA (2008) Modeling the effects of fluoxetine on food-reinforced behavior. Behav Pharmacol 19:61-70
87. 2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behaviour. Psychopharmacology 227:55-66
88. 1B receptors in entrainment disorder of Otsika Long Evans Tokushima Fatty (OLETF) rats. Neuroscience 123:201-205
89. Skjoldager P, Pierre PJ, Mittleman G (1993) Reinforcer magnitude and progressive ratio responding in the rat: effects of increased effort, prefeeding, and extinction. Learn Motiv 24:303-343
90. Stafford D, Branch MN (1998) Effects of step size and break-point criterion on progressive-ratio performance. J Exp Anal Behav 70:123-138
91. 2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice. Neuropharmacology 52:949-957
92. Stubbs DA (1976) Scaling of stimulus durations by pigeons. J Exp Anal Behav 26:15-25
93. 2C receptors in modifying ethanol self-administration behaviour. Pharmacol Biochem Behav 71:735-744
94. Valencia-Torres L, Bradshaw CM, Bouzas A, Hong E, Orduña V (2014) Effect of streptozotocin-induced diabetes on performance on a progressive ratio schedule. Psychopharmacology 231:2375-2384
95. 2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. J Pharm Exp Ther 325:567-576
96. 2C receptor agonists in the pigeon. Behav Pharmacol 11:355-364
97. Wright FL, Rodgers RJ (2014) On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination. Psychopharmacology 231:787-800
98. Wynne CDL, Staddon JER, Delius JD (1996) Dynamics of waiting in pigeons. J Exp Anal Behav 65:603-618